New strategies healthcare


"New Markets Advisors really understands healthcare transformation, and the team is both rigorous and imaginative in figuring out its business implications."

Nicole Wahl,
Manager of New Product Planning, Boston Scientific

"New Markets Advisors did an excellent job of providing our team with a 'jobs-to-be-done' framework for generating customer-centric product requirements. Their consultants have a knack for outlining the theories and then applying them in creative and engaging ways."

Paul Conrad,
Vice President, Global Hip Product Mgt., Zimmer

"New Markets Advisors did a wonderful job synthesizing a broad array of original and secondary research into fresh, actionable business concepts for our organization.  I was impressed by how deeply their team understands healthcare industry trends, the clarity of their new business opportunity analysis process and their ability to bring disparate insights together in a meaningful way."

Teresa Marchek,
Business Development Director, Capella Education

“Very effective at collaborating with teams to make a big and ambiguous strategic opportunity into a clear and actionable project plan. These plans are built off of customer insights and position the company to bring disruptive innovation into the market place.”

Michelle Brennan,
Ethicon Endo-Surgery EMEA
(a Johnson & Johnson company)

"Based on experience with Steve Wunker in two different companies in very different segments of the healthcare industry, I have been consistently impressed by both the strategic discipline and breakthrough perspective that Steve provides that is essential to building new innovations and growth platforms. Equally important, Steve plays a leadership role with his clients in moving from plan to action as rapidly as possible in order to get real-world learnings on key projects."

Colin Watts,
Chief Innovation Officer,

How to Develop New Strategies for the Transforming Healthcare Landscape

Health reform has accelerated strategic shifts across the U.S. healthcare industry.  Historic business models are being upended by factors such as competitor consolidation, global payments, accountable care, and a move from isolated therapies to disease state solutions.  Firms must re-think traditional approaches to win in the new landscape.  

Equally, companies historically focused on the U.S. may find fertile ground overseas.  Competencies developed in the world's richest healthcare market have real potential in rapidly-developing countries.  Of course firms have to adjust their approaches in new environments, but many have cause for optimism about where expansion overseas could lead.

To win on this shifting ground, companies need to look objectively at where profits will lie in coming years.  If firms can address the coming “pain points” in medicine, they will do very well.  For instance, healthcare firms tend to be Balkanized by product class – drug makers, device manufacturers, IT integrators and so on – while their customers are seeking over-arching solutions to address increasingly complex care pathways, pay-for-performance incentives, and patient self-management.

New Markets has extensive experience in healthcare and sees an urgent need for firms in this industry to think freshly about their strategies.  Moreover, companies will need to approach commercialization in a more nimble fashion than usual, given how quickly change is happening. 

Healthcare has tremendous headroom for profitable innovation.  Click at left to download our thoughts on how to navigate these new markets.

Other Areas of Expertise:

Explore Our Services:

Download Our Presentation on the Healthcare Innovation Today

Our presentation covers the innovation implications of the Affordable Care Act and other trends in the healthcare industry, as well as how healthcare organizations can approach innovation challenges and opportunities in this new market environment.

Click here to download.